- Market Realist•11 minutes ago
Pfizer (PFE) won access to Medivation’s (MDVN) key drug Xtandi following the acquisition. Xtandi is the top-selling prostate cancer drug.
- Investor's Business Daily•36 minutes ago
Bowing to political pressure, Mylan's generics arm will sell a cut-rate version of its own best-selling product.
- Market Realist•1 hour ago
Medivation’s portfolio complements Pfizer’s existing oncology portfolio that includes solid tumors, hematology, and immunology-oncology.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||34.98 x 3100|
|Ask||34.99 x 7400|
|Day's Range||34.81 - 35.05|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||31.07|
|Avg Vol (3m)||22,033,106|
|Dividend & Yield||1.20 (3.45%)|